Internal Medicine, Gastroenterology · Florham Park, NJ
NPI
1215944582
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
140 Park Ave
Florham Park, NJ, 07932
Phone (973) 401-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
2,194 services
Medicare patients, 2024
1,184
Average age 74
Drug cost, 2024
$729K
1,850 prescriptions
Company payments, 2025
$1,692
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Dalena was code 99213 (office e&m - established), 439 times for 370 patients. In total John M Dalena billed 2,194 services in 81 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 439 | 370 | $75.52 | $33K |
| 99214 Office E&M - Established | Office | 286 | 248 | $105.37 | $30K |
| 43239 Upper GI Endoscopy | Facility | 251 | 246 | $84.86 | $21K |
| 45385 Colonoscopy - Lesion Removal | Facility | 247 | 247 | $218.18 | $54K |
| 45380 Lower GI Endoscopy - Other | Facility | 109 | 109 | $143.21 | $16K |
| 45378 Lower GI Endoscopy - Other | Facility | 108 | 107 | $149.20 | $16K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 99 | 99 | $192.54 | $19K |
| 99212 Office E&M - Established | Office | 87 | 86 | $47.39 | $4,123 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 72 | 72 | $194.59 | $14K |
| 99203 Office E&M - New | Office | 67 | 67 | $92.66 | $6,208 |
| 99204 Office E&M - New | Office | 46 | 46 | $131.13 | $6,032 |
| 36415 Venipuncture Blood Collection | Office | 38 | 35 | $8.65 | $329 |
| 80053 Clinical Chemistry | Office | 24 | 23 | $10.35 | $248 |
| 83993 Clinical Chemistry | Office | 17 | 15 | $19.24 | $327 |
| 85025 Blood Count | Office | 16 | 16 | $7.61 | $122 |
By year: 2022 $245K for 2,554 services; 2023 $234K for 2,453 services; 2024 $229K for 2,194 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 35 | $8.65 | $329 |
| 80053 Clinical Chemistry | 24 | 23 | $10.35 | $248 |
| 83993 Clinical Chemistry | 17 | 15 | $19.24 | $327 |
| 85025 Blood Count | 16 | 16 | $7.61 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug John M Dalena prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 535 prescriptions and refills. In total John M Dalena wrote 1,850 Medicare prescriptions that cost $729K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 535 | 535 | 525 | $35K |
| Pantoprazole Sodium Generic | 237 | 615 | 74 | $4,133 |
| Omeprazole Generic | 187 | 518 | 59 | $2,419 |
| Mesalamine Generic | 79 | 209 | 21 | $65K |
| Esomeprazole Magnesium Generic | 78 | 200 | 29 | $3,326 |
| Famotidine Generic | 74 | 198 | 25 | $1,275 |
| Dexlansoprazole Dr Dexlansoprazole | 48 | 112 | 11 | $21K |
| Linzess Linaclotide | 38 | 56 | Under 11 | $29K |
| Creon Lipase/Protease/Amylase | 37 | 70 | 11 | $106K |
| Ursodiol Generic | 35 | 91 | Under 11 | $7,695 |
| Colestipol Hcl Generic | 25 | 55 | Under 11 | $3,385 |
| Cholestyramine Cholestyramine (With Sugar) | 22 | 48 | Under 11 | $2,194 |
| Ondansetron Odt Ondansetron | 20 | 22 | 11 | $470 |
| Ondansetron Hcl Generic | 19 | 23 | 12 | $619 |
| Balsalazide Disodium Generic | 19 | 27 | Under 11 | $3,674 |
Brand drugs: - claims; generic drugs: 1,448 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Dalena $1,692 ($1,692 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $505.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 23 | $505 |
| Abbvie Inc. ABBV | 20 | $322 |
| Janssen Biotech, Inc. JNJ | 12 | $219 |
| Celltrion USA Inc. 068270.KS | 11 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $149 |
| Intercept Pharmaceuticals, Inc. | 4 | $80.87 |
| Ardelyx, Inc. ARDX | 4 | $66.74 |
| PENTAX of America, Inc. | 2 | $44.31 |
| Madrigal Pharmaceuticals MDGL | 2 | $41.54 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $33.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.